Targeting protein folding: A novel approach for the treatment of pathogenic bacteria

Scheuplein, N.J., Bzdyl, N.M., Kibble, E.A., Lohr, T., Holzgrabe, U. and Sarkar-Tyson, M. (2020) Targeting protein folding: A novel approach for the treatment of pathogenic bacteria. Journal of Medicinal Chemistry, 63 (22). pp. 13355-13388.

Abstract

Infectious diseases are a major cause of morbidity and mortality worldwide, exacerbated by increasing antibiotic resistance in many bacterial species. The development of drugs with new modes of action is essential. A leading strategy is antivirulence, with the aim to target bacterial proteins that are important in disease causation and progression but do not affect growth, resulting in reduced selective pressure for resistance. Immunophilins, a superfamily of peptidyl-prolyl cis–trans isomerase (PPIase) enzymes have been shown to be important for virulence in a broad-spectrum of pathogenic bacteria. This Perspective will provide an overview of the recent advances made in understanding the role of each immunophilin family, cyclophilins, FK506 binding proteins (FKBPs), and parvulins in bacteria. Inhibitor design and medicinal chemistry strategies for development of novel drugs against bacterial FKBPs will be discussed. Furthermore, drugs against human cyclophilins and parvulins will be reviewed in their current indication as antiviral and anticancer therapies.

Item Type:	Journal Article
Murdoch Affiliation(s):	School of Veterinary and Life Sciences
Publisher:	American Chemical Society
Copyright:	© 2020 American Chemical Society
URI:	http://researchrepository.murdoch.edu.au/id/eprint/58969

Item Control Page